Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „golimumab“
Suchtreffer
Begriffe & Kennungen
Gotenfia · 4.5 · Therapeutic infectious agents should not be given concurrently with golimumab (see section 4.4).
Eintrag öffnenGotenfia · 4.5 · Therapeutic infectious agents should not be given concurrently with golimumab (see section 4.4).
Eintrag öffnenGotenfia · 4.8 · 45 was diagnosed in 11 subjects (1 in the golimumab 50 mg treatment groups and 10 in the golimumab 100 mg trea
Eintrag öffnenGotenfia · 4.8 · 46 elevations was 24.7% in patients receiving golimumab during the maintenance portion of the UC study.
Eintrag öffnenGotenfia · 4.8 · In the controlled period of pivotal trials, infections were observed in 23.0% of golimumab-treated patients (i
Eintrag öffnenGotenfia · 4.8 · In the controlled period of pivotal trials, infections were observed in 23.0% of golimumab-treated patients (i
Eintrag öffnenGotenfia · 4.8 · Injection site reactions In the controlled periods of pivotal trials, 5.4% of golimumab-treated patients had i
Eintrag öffnenGotenfia · 4.8 · Injection site reactions In the controlled periods of pivotal trials, 5.4% of golimumab-treated patients had i
Eintrag öffnenGotenfia · 4.8 · Malignancies Lymphoma The incidence of lymphoma in golimumab-treated patients during the pivotal trials was hi
Eintrag öffnenGotenfia · 4.8 · Malignancies Lymphoma The incidence of lymphoma in golimumab-treated patients during the pivotal trials was hi
Eintrag öffnenGotenfia · 4.8 · Paediatric population Polyarticular juvenile idiopathic arthritis The safety of golimumab has been studied in
Eintrag öffnenGotenfia · 4.8 · Paediatric population Ulcerative colitis The safety of golimumab has been studied in a Phase III study of 69 p
Eintrag öffnenGotenfia · 4.8 · Ulcerative colitis The safety of golimumab has been studied in a Phase III study of 69 patients from 4 to 17 y
Eintrag öffnenSimponi · 4.5 · Concurrent use with other biological therapeutics The combination of golimumab with other biological therapeut
Eintrag öffnenSimponi · 4.5 · Concurrent use with other biological therapeutics The combination of golimumab with other biological therapeut
Eintrag öffnenSimponi · 4.5 · Concurrent use with other biological therapeutics The combination of golimumab with other biological therapeut
Eintrag öffnenSimponi · 4.5 · Concurrent use with other biological therapeutics The combination of golimumab with other biological therapeut
Eintrag öffnenSimponi · 4.5 · Concurrent use with other biological therapeutics The combination of golimumab with other biological therapeut
Eintrag öffnenSimponi · 4.5 · Live vaccines/therapeutic infectious agents Live vaccines should not be given concurrently with golimumab (see
Eintrag öffnenSimponi · 4.5 · Live vaccines/therapeutic infectious agents Live vaccines should not be given concurrently with golimumab (see
Eintrag öffnen